XML 54 R15.htm IDEA: XBRL DOCUMENT v3.25.0.1
Marketable Securities
12 Months Ended
Dec. 31, 2024
Marketable Securities [Abstract]  
Marketable Securities

4. Marketable Securities

Available-for-sale marketable securities were as follows (in thousands):

 

 

December 31, 2024

 

 

Amortized
Cost

 

 

Unrealized
Gains

 

 

Unrealized
Losses

 

 

Fair Value

 

Government agency

 

519,125

 

 

 

1,007

 

 

 

(159

)

 

 

519,973

 

Total

$

519,125

 

 

$

1,007

 

 

$

(159

)

 

$

519,973

 

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31, 2023

 

 

Amortized
Cost

 

 

Unrealized
Gains

 

 

Unrealized
Losses

 

 

Fair Value

 

Commercial paper

$

26,752

 

 

$

 

 

$

(15

)

 

$

26,737

 

Corporate debt

 

5,988

 

 

 

 

 

 

(7

)

 

 

5,982

 

Government agency

 

301,315

 

 

 

584

 

 

 

(16

)

 

 

301,884

 

Total

$

334,056

 

 

$

584

 

 

$

(38

)

 

$

334,602

 

 

The fair value of available-for-sale marketable securities by contractual maturity as of December 31, 2024 and 2023 were as follows (in thousands):

 

 

December 31,

 

 

2024

 

 

2023

 

Due in 1 year or less

$

481,696

 

 

$

307,434

 

Due in 1 - 2 years

 

38,277

 

 

 

27,168

 

Total

$

519,973

 

 

$

334,602

 

 

The Company had 9 securities in an unrealized loss position with an aggregate related fair value of $108.4 million as of December 31, 2024. The Company had 8 securities in an unrealized loss position with an aggregate related fair value of $61.5 million as of December 31, 2023. All securities in an unrealized loss position as of December 31, 2024 and 2023 had been in a loss position for less than twelve months. Unrealized losses on available-for-sale marketable securities as of December 31, 2024 and 2023 were not significant and were primarily due to changes in interest rates, including market credit spreads, and not due to increased credit risks associated with specific securities. Accordingly, no allowance for credit losses related to the Company’s available-for-sale marketable securities was recorded for the years ended December 31, 2024 and 2023. The Company does not intend to sell these securities and it is unlikely that the Company will be required to sell the investments before recovery of their amortized cost bases, which may be at maturity.

 

As of December 31, 2024 and 2023, the Company recognized $2.5 million and $1.4 million, respectively, of accrued interest receivable from available-for-sale securities within prepaid expenses and other current assets on the consolidated balance sheets.